The War Ends Between Cipla and Roche Relating To Anti Cancer Drug Elontinib Hydrochloride

Dispute relating to anti cancer drug Elontinib Hydrochloride , between Cipla and Roche (being one of the initial patent disputes post 2005 TRIPS compliance) , has been resolved as both the parties have reached “out of court” settlement.The two companies on May 30 2017, arrived at a settlement before the Delhi High Court to close the patent dispute between them over the said drug. 

The said drug Erlotinib Hydrochloride  sold by Roche under brand Tarceva cost around Rs 1.4 lakh for a month’s dosage,  used in treatment of non-small cell lung cancer (NSCLC), pancreatic cancer and several other types of cancer. A patent infringement case was filed by Roche against Cipla for selling another version of said drug  at one third of Roche's price. In 2015, The Delhi High Court  held Cipla guilty of infringing Roche’s patent . Cipla then approached Supreme Court challenging the said order and contended that Roche’s product Tarceva was subject matter of a rejected patent application in India and was therefore in public domain, for which it has been accused of infringement. 

In recent developments, Cipla has now acknowledged Roche's Patent rights over the said drug and has withdrawn the Special Leave Petition  filed in the Supreme Court against the said Delhi High Court Order,  resulting in both the parties ending litigation on the said drug. 

India And Japan Sign Biennial Intellectual Property Action Plan For 2017-2019

Indian Controller General of Patents, Designs & Trade Marks and Deputy Commissioner of Japan Patent Office signed the biennial action plan for 2017-2019 on 24 th May, 2017 at Mumbai on cooperation between the office of CGPDTM and Japan Patent Office under Memorandum of Cooperation on Industrial Property. The said biennial action plan aims at exchange of information on search and examination practices, organizing awareness in both countries to facilitate promotion, creation and commercialization of IP Assets besides training courses for newly recruited examiners, other officials, persons engaged in IP related matters in public organization, academic institutions, R & D Institutions, Startups, MSMEs, and newly registered patent agents, etc

Source : Govt. Notification 

Your Amazon Package Might Be Delivered By Air Drones In Future!

Imagine your online purchase being delivered by a drone at your doorstep!

E-Commerce giant Amazon has made this possible with successful demonstration in U.S regarding usefulness of Air Drones in fast and efficient delivery.

Amazon is seeking Patent for such technology in U.S , Canada and India under the title 'Propeller safety for automated aerial vehicles (AAV)'. 

Although obtaining the Patent hasn't been easy yet , since the United States Patent and Trademark Office (USPTO) has seriously objected to patent for this technology and such objections might have a bearing on the fate of Indian Patent Application. 

Source : thehindu.com

Now Your Face Will Be An Emoji on Facebook

According to a recent patent granted to Facebook, When a user enters a emoji in a comment or message thread, Facebook will identify an image of the user that corresponds to the selected emoji.Such as an image of the person smiling in exchange for a smiley emoticon. The system will then replace your generic emoji with the small photo of you.

Source

www.cnbc.com